News | April 01, 2026
Rusan unveils APOSAN 3ml multi-dose pen
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery
The decision is based on the phase 3 DESTINY-Breast11 trial
Since launching, the hospital has performed over 40 intestinal transplants, including 21 in 2025 alone
The radiotherapy systems include TrueBeam, TrueBeam STx, VitalBeam, and Edge
At the center of the collapse is opposition from the Federal Trade Commission
AstraZeneca says the approval strengthens its push to bring immunotherapy earlier into cancer treatment, where long-term cures are possible
The framework introduces 15 consensus terms and definitions grouped across four core dimensions of skin health
The trial will enroll up to 42 patients in Finland across four cohorts
The trial’s primary goal is to evaluate vipoglanstat’s effect on endometriosis-related pain during non-menstrual days
Subscribe To Our Newsletter & Stay Updated
